COM:MOLEKULE
MOLEKULE
- Stock
Last Close
0.09
12/10 20:00
Market Cap
1.87M
Beta: -
Volume Today
7.88M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|
average inventory | 322.97K - | 13.36M 4,035.93% | |||
average payables | 238.40K - | 629.63K 164.11% | 5.89M 834.80% | ||
average receivables | 50.27K - | 138.80K 176.11% | 488.85K 252.19% | ||
book value per share | -0.02 - | 0.18 1,196.07% | 2.03 1,015.30% | -1.76 186.35% | |
capex per share | -0.03 - | -0.16 399.36% | -0.18 9.77% | ||
capex to depreciation | -21.95 - | -0.48 97.80% | |||
capex to operating cash flow | 0.15 - | 0.25 69.28% | 0.07 73.08% | ||
capex to revenue | -2.84 - | -0.06 97.95% | |||
cash per share | 0.00 - | 0.17 293,005.15% | 1.84 992.58% | 0.15 91.68% | |
days of inventory on hand | 695.70 - | 292.99 57.89% | |||
days payables outstanding | 998.61 - | 121.88 87.80% | |||
days sales outstanding | 104.83 - | 6.08 94.20% | |||
debt to assets | 108.92 - | 0.89 - | |||
debt to equity | -0.38 - | -1.72 - | |||
dividend yield | |||||
earnings yield | -0.00 - | -0.00 2,075.96% | -0.07 2,234.59% | -0.03 54.86% | |
enterprise value | 1.09B - | 1.09B 0.22% | 92.15M 91.56% | 92.85M 0.76% | |
enterprise value over ebitda | -7.17K - | -328.63 95.41% | -11.18 96.60% | 11.14 199.62% | |
ev to operating cash flow | -11.44K - | -355.72 96.89% | -13.21 96.29% | -2.25 82.98% | |
ev to sales | 149.46 - | 1.93 98.71% | |||
free cash flow per share | -0.01 - | -0.25 3,584.14% | -0.82 221.35% | -2.84 248.03% | |
free cash flow yield | -0.00 - | -0.00 3,584.14% | -0.08 2,322.88% | -0.91 1,064.19% | |
graham net net | -0.02 - | 0.13 855.85% | 1.69 1,246.35% | -4.10 342.16% | |
graham number | 0.06 - | 0.99 1,444.35% | 5.83 487.66% | 1.99 65.86% | |
income quality | 0.63 - | 0.92 47.47% | 0.88 4.73% | 26.59 2,921.53% | |
intangibles to total assets | 0 - | 0 | 0 | 0.04 Infinity% | |
interest coverage | -7.96 - | ||||
interest debt per share | 0.01 - | 3.28 - | |||
inventory turnover | 0.52 - | 1.25 137.45% | |||
invested capital | -0.38 - | -1.72 - | |||
market cap | 1.09B - | 1.09B 0% | 111.78M 89.79% | 48.51M 56.60% | |
net current asset value | -230.63K - | 2.07M 998.92% | 19.57M 843.73% | -48.62M 348.48% | |
net debt to ebitda | -0.56 - | 0.70 224.82% | 2.38 239.15% | 5.32 123.34% | |
net income per share | -0.01 - | -0.24 2,075.96% | -0.74 209.64% | -0.10 86.50% | |
operating cash flow per share | -0.01 - | -0.22 3,108.89% | -0.65 194.99% | -2.66 307.77% | |
payables turnover | 0.37 - | 2.99 719.35% | |||
receivables turnover | 3.48 - | 59.99 1,622.88% | |||
research and ddevelopement to revenue | 6.80 - | 0.04 99.40% | |||
return on tangible assets | -191.86 - | -1.04 99.46% | -0.33 67.90% | -0.03 90.77% | |
revenue per share | 0.06 - | 3.10 5,266.72% | |||
roe | 0.66 - | -1.31 298.52% | -0.36 72.24% | 0.06 115.63% | |
roic | 1.06 - | -1.31 223.89% | -0.36 72.24% | -29.02 7,850.27% | |
sales general and administrative to revenue | 0.81 - | ||||
shareholders equity per share | -0.02 - | 0.18 1,196.07% | 2.03 1,015.30% | -1.76 186.35% | |
stock based compensation to revenue | 1.93 - | 0.03 98.43% | |||
tangible asset value | -230.63K - | 2.53M 1,196.07% | 21.71M 758.84% | -29.18M 234.40% | |
tangible book value per share | -0.02 - | 0.18 1,196.07% | 2.03 1,015.30% | -1.92 194.58% | |
working capital | -230.63K - | 2.07M 998.92% | 20.07M 867.91% | 10.60M 47.18% |
All numbers in USD (except ratios and percentages)